Clinical Trial Update: Effect of PP-01 on Cannabis Withdrawal Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PP-01 for cannabis withdrawal syndrome has completed; the update does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Withdrawal

Drugs mentioned

• PP-01

Snippet

Sponsor: PleoPharma, Inc. | Conditions: Cannabis Withdrawal | Phase 2 | Status: COMPLETED